oral hypoglycaemic drugs

oral hypoglycaemic drugs

agents, e.g. biguanides, sulphonylureas, acarbose and glitazones, taken by mouth to treat diabetes mellitus, and achieve normoglycaemia
References in periodicals archive ?
It is comparatively free of significant side effects and unlike most other oral hypoglycaemic drugs lacks a significant risk of producing hypoglycaemia, which itself can also increase cardiovascular risk.
The 65s and over Anyone with a serious medical condition, particularly children with long term conditions of chronic respiratory disease, heart disease, renal disease and chronic liver disease, diabetes requiring insulin or oral hypoglycaemic drugs and immunosuppression.
Anyone with an underlying health condition including: Chronic respiratory disease, such as chronic obstructive pulmonary disease (COPD); Chronic heart disease; Chronic kidney disease, such as kidney failure; Chronic liver disease; Chronic neurological disease; Diabetes requiring insulin or oral hypoglycaemic drugs and immunosuppression.